151 related articles for article (PubMed ID: 23156300)
1. [Pathology of ovarian cancer].
Kaku T; Watanabe S; Ohishi Y
Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
[No Abstract] [Full Text] [Related]
2. [Pathology of ovarian cancer].
Kaku T; Ogawa S; Hirakawa T; Ohishi Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():471-5. PubMed ID: 15535290
[No Abstract] [Full Text] [Related]
3. Cytopathology of ovarian lesions: the intraoperative approach.
Jiménez-Ayala M; Jiménez-Ayala Portillo B
Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
[No Abstract] [Full Text] [Related]
4. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
5. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
6. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
Mutch DG; Prat J
Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
[No Abstract] [Full Text] [Related]
7. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
8. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
9. [Cytology of ovarian epithelial tumors].
Otsuki T; Yaegashi N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():503-6. PubMed ID: 15535296
[No Abstract] [Full Text] [Related]
10. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
Kempson RL; Hendrickson MR
Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
12. [Pathological diagnosis of ovarian cancer].
Yamabe H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():507-10. PubMed ID: 15535297
[No Abstract] [Full Text] [Related]
13. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
14. [Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features].
Guo DH; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):624-8. PubMed ID: 24314254
[No Abstract] [Full Text] [Related]
15. TTF-1 expression in primary ovarian epithelial neoplasia.
Graham AD; Williams AR; Salter DM
Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695
[No Abstract] [Full Text] [Related]
16. Surface epithelial tumours of the ovary.
Maheshwari V; Tyagi SP; Saxena K; Tyagi N; Sharma R; Aziz M; Hameed F
Indian J Pathol Microbiol; 1994 Jan; 37(1):75-85. PubMed ID: 8088904
[TBL] [Abstract][Full Text] [Related]
17. Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
Köbel M; Kalloger SE; Huntsman DG; Santos JL; Swenerton KD; Seidman JD; Gilks CB;
Int J Gynecol Pathol; 2010 May; 29(3):203-11. PubMed ID: 20407318
[TBL] [Abstract][Full Text] [Related]
18. [Survival of patients with ovarian cancer in the Ul'ianovsk Region, 1999-2005].
Antoneeva II
Vopr Onkol; 2007; 53(4):393-5. PubMed ID: 17969399
[No Abstract] [Full Text] [Related]
19. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin.
Sato S; Okamoto S; Ito K; Konno R; Yajima A
Acta Cytol; 2000; 44(3):485-8. PubMed ID: 10834020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
